February 17, 2021
Biogen, headquartered in Cambridge, Massachusetts, is a pioneer in biotechnology and discovers, develops and delivers innovative therapies worldwide for people living with serious neurological and neurodegenerative diseases.
Biogen works to have an impact beyond their medicines as they strive to improve patient health outcomes, solve social and environmental challenges, cultivate a workplace that enables their employees to thrive, support local communities, and inspire future generations of scientists.
After achieving carbon neutrality in 2014, Biogen further bolsters its action against climate change with the goal to become fossil fuel free by 2040 through Biogen’s Healthy Climate, Healthy Lives™, a groundbreaking $250 million, 20-year initiative.
Healthy Climate, Healthy Lives has two principal components:
1. Biogen pledged to become fossil fuel free, eliminating emissions on an accelerated timeframe, going far beyond carbon neutral. Learn how Biogen aims to go fossil fuel free here.
2. Biogen is collaborating with global leaders including Harvard T.H. Chan School and MIT to use data science and predictive analytics to drive strategies to mitigate environmental and health impacts from climate change as well as influence policy and improve health outcomes, particularly for the world’s most vulnerable populations. Learn more about the collaboration here.